S100A10, a novel biomarker in pancreatic ductal adenocarcinoma

Pancreatic cancer is arguably the deadliest cancer type. The efficacy of current therapies is often hindered by the inability to predict patient outcome. As such, the development of tools for early detection and risk prediction is key for improving outcome and quality of life. Here, we introduce the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Oncol
Hlavní autoři: Bydoun, Moamen, Sterea, Andra, Liptay, Henry, Uzans, Andrea, Huang, Weei‐Yuarn, Rodrigues, Gloria J., Weaver, Ian C.G., Gu, Hong, Waisman, David M.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6210040/
https://ncbi.nlm.nih.gov/pubmed/30009399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12356
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky